Preclinical development of HQP1351, a multikinase inhibitor targeting a broad spectrum of mutant KIT kinases, for the treatment of imatinib-resistant gastrointestinal stromal tumors
HQP1351 是一种针对多种突变型 KIT 激酶的多激酶抑制剂，用于治疗伊马替尼耐药的胃肠道间质瘤的临床前开发
期刊:Cell and Bioscience
影响因子:6.1
doi:10.1186/s13578-019-0351-6
Xuechao Liu #, Guangfeng Wang #, Xianglei Yan #, Haibo Qiu, Ping Min, Miaoyi Wu, Chunyang Tang, Fei Zhang, Qiuqiong Tang, Saijie Zhu, Miaozhen Qiu, Wei Zhuang, Douglas D Fang, Zhiwei Zhou #, Dajun Yang #, Yifan Zhai #
